The Latest
Rhythm Pharmaceuticals Announces The New England Journal Of Medicine Publication Of Phase 3 TRANSCEND Trial Results In Acquired Hypothalamic Obesity
Rhythm Pharmaceuticals announced the publication of phase 3 TRANSCEND trial results on acquired hypothalamic obesity in the New England Journal of Medicine.